Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Waldemar Priebe

Showing results (61-70 of 128) with videos related to

Pageof 13
Sort By:
Investigational New Drugs|April 19, 2017
Bis-anthracycline WP760 abrogates melanoma cell growth by transcription inhibition, p53 activation and IGF1R downregulationMagdalena Olbryt, Aleksandra Rusin, Izabela Fokt, et al.
Biomedicines|December 24, 2021
Synergistic Anticancer Effect of Glycolysis and Histone Deacetylases Inhibitors in a Glioblastoma ModelBeata Pająk, Ewelina Siwiak-Niedbalska, Anna Jaśkiewicz, et al.
Cancer Research|October 19, 2007
A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patientsS Farzana Hussain, Ling-Yuan Kong, Justin Jordan, et al.
Acta Poloniae Pharmaceutica|July 19, 2005
Constitutive activation of transcription factor NFkappaB as a possible marker of sensitivity of neoplastic cells to anthracyclinesBeata M Gruber, Elzbieta L Anuszewska, Irena Bubko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
WP1066, a novel JAK2 inhibitor, suppresses proliferation and induces apoptosis in erythroid human cells carrying the JAK2 V617F mutationSrdan Verstovsek, Taghi Manshouri, Alfonso Quintás-Cardama, et al.
Plos One|May 9, 2014
Inhibition of the JAK2/STAT3 pathway reduces gastric cancer growth in vitro and in vivoLouise M Judd, Treve R Menheniott, Hui Ling, et al.
Surgery|September 10, 2002
Importance of Sp1 consensus motifs in the MYCN promoterThomas H Inge, Lavona K Casson, Waldemar Priebe, et al.
Cancer Chemotherapy and Pharmacology|February 23, 2011
A genistein derivative, ITB-301, induces microtubule depolymerization and mitotic arrest in multidrug-resistant ovarian cancerAhmed Ashour Ahmed, Juliet Goldsmith, Izabela Fokt, et al.
Plos One|February 2, 2011
Hypoxia potentiates glioma-mediated immunosuppressionJun Wei, Adam Wu, Ling-Yuan Kong, et al.
Cancer Research|January 20, 2004
2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivoGregory Maschek, Niramol Savaraj, Waldemar Priebe, et al.
Pageof 13

Showing results (61-70 of 128) with videos related to

Sort By:
Pageof 13
Investigational New Drugs|April 19, 2017
Bis-anthracycline WP760 abrogates melanoma cell growth by transcription inhibition, p53 activation and IGF1R downregulationMagdalena Olbryt, Aleksandra Rusin, Izabela Fokt, et al.
Biomedicines|December 24, 2021
Synergistic Anticancer Effect of Glycolysis and Histone Deacetylases Inhibitors in a Glioblastoma ModelBeata Pająk, Ewelina Siwiak-Niedbalska, Anna Jaśkiewicz, et al.
Cancer Research|October 19, 2007
A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patientsS Farzana Hussain, Ling-Yuan Kong, Justin Jordan, et al.
Acta Poloniae Pharmaceutica|July 19, 2005
Constitutive activation of transcription factor NFkappaB as a possible marker of sensitivity of neoplastic cells to anthracyclinesBeata M Gruber, Elzbieta L Anuszewska, Irena Bubko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
WP1066, a novel JAK2 inhibitor, suppresses proliferation and induces apoptosis in erythroid human cells carrying the JAK2 V617F mutationSrdan Verstovsek, Taghi Manshouri, Alfonso Quintás-Cardama, et al.
Plos One|May 9, 2014
Inhibition of the JAK2/STAT3 pathway reduces gastric cancer growth in vitro and in vivoLouise M Judd, Treve R Menheniott, Hui Ling, et al.
Surgery|September 10, 2002
Importance of Sp1 consensus motifs in the MYCN promoterThomas H Inge, Lavona K Casson, Waldemar Priebe, et al.
Cancer Chemotherapy and Pharmacology|February 23, 2011
A genistein derivative, ITB-301, induces microtubule depolymerization and mitotic arrest in multidrug-resistant ovarian cancerAhmed Ashour Ahmed, Juliet Goldsmith, Izabela Fokt, et al.
Plos One|February 2, 2011
Hypoxia potentiates glioma-mediated immunosuppressionJun Wei, Adam Wu, Ling-Yuan Kong, et al.
Cancer Research|January 20, 2004
2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivoGregory Maschek, Niramol Savaraj, Waldemar Priebe, et al.
Pageof 13